Up | AC
Home Page
Food and
Drug Administration
Meeting of the Nonprescription Drugs Advisory Committee
December 14, 2007
BRIEFING INFORMATION
Schering-Plough Corporation
Briefing Material (pdf)
Schering-Plough Merck Pharmaceuticals
Briefing Material (pdf)
CHPA
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Consumer Healthcare Products Association (CHPA)
Briefing Material (pdf)
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material, Volume 1 (pdf) Volume 2 (pdf)